211 related articles for article (PubMed ID: 21797841)
21. Isoobtusilactone A sensitizes human hepatoma Hep G2 cells to TRAIL-induced apoptosis via ROS and CHOP-mediated up-regulation of DR5.
Chen CY; Yiin SJ; Hsu JL; Wang WC; Lin SC; Chern CL
J Agric Food Chem; 2012 Apr; 60(13):3533-9. PubMed ID: 22400995
[TBL] [Abstract][Full Text] [Related]
22. Bakuchiol sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins.
Park MH; Kim JH; Chung YH; Lee SH
Biochem Biophys Res Commun; 2016 Apr; 473(2):586-92. PubMed ID: 27033605
[TBL] [Abstract][Full Text] [Related]
23. Piperlongumine induces cell death through ROS-mediated CHOP activation and potentiates TRAIL-induced cell death in breast cancer cells.
Jin HO; Lee YH; Park JA; Lee HN; Kim JH; Kim JY; Kim B; Hong SE; Kim HA; Kim EK; Noh WC; Kim JI; Chang YH; Hong SI; Hong YJ; Park IC; Lee JK
J Cancer Res Clin Oncol; 2014 Dec; 140(12):2039-46. PubMed ID: 25023940
[TBL] [Abstract][Full Text] [Related]
24. Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors.
Sung B; Park B; Yadav VR; Aggarwal BB
J Biol Chem; 2010 Apr; 285(15):11498-507. PubMed ID: 20154087
[TBL] [Abstract][Full Text] [Related]
25. Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation.
Chen L; Meng Y; Sun Q; Zhang Z; Guo X; Sheng X; Tai G; Cheng H; Zhou Y
Cell Death Dis; 2016 Aug; 7(8):e2334. PubMed ID: 27512955
[TBL] [Abstract][Full Text] [Related]
26. Snake venom toxin from Vipera lebetina turanica sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins.
Park MH; Jo M; Won D; Song HS; Song MJ; Hong JT
Apoptosis; 2012 Dec; 17(12):1316-26. PubMed ID: 23007278
[TBL] [Abstract][Full Text] [Related]
27. Indomethacin sensitizes TRAIL-resistant melanoma cells to TRAIL-induced apoptosis through ROS-mediated upregulation of death receptor 5 and downregulation of survivin.
Tse AK; Cao HH; Cheng CY; Kwan HY; Yu H; Fong WF; Yu ZL
J Invest Dermatol; 2014 May; 134(5):1397-1407. PubMed ID: 24213373
[TBL] [Abstract][Full Text] [Related]
28. Pterostilbene Enhances TRAIL-Induced Apoptosis through the Induction of Death Receptors and Downregulation of Cell Survival Proteins in TRAIL-Resistance Triple Negative Breast Cancer Cells.
Hung CM; Liu LC; Ho CT; Lin YC; Way TD
J Agric Food Chem; 2017 Dec; 65(51):11179-11191. PubMed ID: 29164887
[TBL] [Abstract][Full Text] [Related]
29. 5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells.
Yang JF; Cao JG; Tian L; Liu F
Cancer Chemother Pharmacol; 2012 Jan; 69(1):195-206. PubMed ID: 21660448
[TBL] [Abstract][Full Text] [Related]
30. Medicarpin, a legume phytoalexin sensitizes myeloid leukemia cells to TRAIL-induced apoptosis through the induction of DR5 and activation of the ROS-JNK-CHOP pathway.
Trivedi R; Maurya R; Mishra DP
Cell Death Dis; 2014 Oct; 5(10):e1465. PubMed ID: 25321472
[TBL] [Abstract][Full Text] [Related]
31. Verrucarin A sensitizes TRAIL-induced apoptosis via the upregulation of DR5 in an eIF2α/CHOP-dependent manner.
Moon DO; Asami Y; Long H; Jang JH; Bae EY; Kim BY; Choi YH; Kang CH; Ahn JS; Kim GY
Toxicol In Vitro; 2013 Feb; 27(1):257-63. PubMed ID: 22982206
[TBL] [Abstract][Full Text] [Related]
32. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
Kim EH; Yoon MJ; Kim SU; Kwon TK; Sohn S; Choi KS
Cancer Res; 2008 Jan; 68(1):266-75. PubMed ID: 18172319
[TBL] [Abstract][Full Text] [Related]
33. Acrolein sensitizes human renal cancer Caki cells to TRAIL-induced apoptosis via ROS-mediated up-regulation of death receptor-5 (DR5) and down-regulation of Bcl-2.
Yang ES; Woo SM; Choi KS; Kwon TK
Exp Cell Res; 2011 Nov; 317(18):2592-601. PubMed ID: 21854768
[TBL] [Abstract][Full Text] [Related]
34. Icariin sensitizes human colon cancer cells to TRAIL‑induced apoptosis via ERK‑mediated upregulation of death receptors.
Kim B; Seo JH; Lee KY; Park B
Int J Oncol; 2020 Mar; 56(3):821-834. PubMed ID: 32124960
[TBL] [Abstract][Full Text] [Related]
35. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
[TBL] [Abstract][Full Text] [Related]
36. Casticin, a flavonoid, potentiates TRAIL-induced apoptosis through modulation of anti-apoptotic proteins and death receptor 5 in colon cancer cells.
Tang SY; Zhong MZ; Yuan GJ; Hou SP; Yin LL; Jiang H; Yu ZΥ
Oncol Rep; 2013 Feb; 29(2):474-80. PubMed ID: 23135489
[TBL] [Abstract][Full Text] [Related]
37. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation.
Jung EM; Park JW; Choi KS; Park JW; Lee HI; Lee KS; Kwon TK
Carcinogenesis; 2006 Oct; 27(10):2008-17. PubMed ID: 16613838
[TBL] [Abstract][Full Text] [Related]
38. Ethanolic extract of Descurainia sophia seeds sensitizes A549 human lung cancer cells to TRAIL cytotoxicity by upregulating death receptors.
Park JS; Lim CJ; Bang OS; Kim NS
BMC Complement Altern Med; 2016 Apr; 16():115. PubMed ID: 27039295
[TBL] [Abstract][Full Text] [Related]
39. Casticin potentiates TRAIL-induced apoptosis of gastric cancer cells through endoplasmic reticulum stress.
Zhou Y; Tian L; Long L; Quan M; Liu F; Cao J
PLoS One; 2013; 8(3):e58855. PubMed ID: 23536831
[TBL] [Abstract][Full Text] [Related]
40. Guggulsterone sensitizes hepatoma cells to TRAIL-induced apoptosis through the induction of CHOP-dependent DR5: involvement of ROS-dependent ER-stress.
Moon DO; Park SY; Choi YH; Ahn JS; Kim GY
Biochem Pharmacol; 2011 Dec; 82(11):1641-50. PubMed ID: 21903093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
